Subtitle
The role of breath hold intensity modulated proton therapy for a case ofleft-sided breast cancer with IMN involvement. How protons compare with other conformal techniques
Subtitle
The role of breath hold intensity modulated proton therapy for a case ofleft-sided breast cancer with IMN involvement. How protons compare with other conformal techniques
Proto therapy Time
March 2020
Check full study
Please connect to access this resource and get a more personalized Campus experience
No account yet? Request access
Executive summary
3D_conformal radiotherapy (3D-CRT), volumetric modulated Arc therapy (VMAT), tomotherapy (TOMO) and intensity modulated proton therapy (IMPT) were compared to identify the best therapy for a patient. The prescribed dose was 40.05Gy, delivered in 15 fractions. The results for this patient suggest that for dose coverage as well as for OAR IMPT seemed to be the best option, whereas for the homogeneity index and the conformity number, TOMO produced the best values. The authors conclude that even though IMPT seems to have the better results, the cost of PT prohibits its application to all patients and recommends to be used in younger patients, for whom sparing of the healthy tissue is far more important
Key content topics
Other popular content
Proton Therapy Publication
December 2021
Technical insights on the treatment of GI cancers.
Proton Therapy Publication
October 2021
Impact of lymphopenia on the clinical outcomes of esophageal cancer patients
Proton Therapy Publication
October 2021
Acute Hematological Outcomes after Proton and Photon Beam Craniospinal Irradiation in Pediatric Brain Tumors
Proton Therapy Publication
October 2021
Acute Hematological Outcomes in Pediatric Brain Tumors
Proton Therapy Publication
October 2021
Comparison of hypothyroidism and adrenal insufficiency in children with medulloblastoma
Proton Therapy Publication
September 2021
Scoping review of patient selection methods for proton therapy
Proton Therapy Publication
September 2021
Dosimetry, efficacy, safety, and cost-effectiveness of PT for NSCLC
Proton Therapy Publication
September 2021
Reduced diffusion in white matter after radiotherapy with photons and protons
Proton Therapy Publication
September 2021
Particle Radiotherapy for Skull Base Chondrosarcoma
Proton Therapy Publication
September 2021
Assessing concordance between patient-reported and investigator-reported CTCAE after PBT for prostate cancer.
Proton Therapy Publication
September 2021
Current status and application of proton therapy for esophageal cancer
Proton Therapy Publication
September 2021
Bicentric Treatment Outcomes following PT for Non-Myxopapillary High-Grade Spinal Cord Ependymoma in Children
Proton Therapy Publication
September 2021
Identifying individualized risk profiles for radiotherapy-induced lymphopenia
Proton Therapy Publication
September 2021
FLASH proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response
Proton Therapy Publication
August 2021
Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma